Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Immatics NV (IMTX)

Immatics NV (IMTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 654,028
  • Shares Outstanding, K 76,227
  • Annual Sales, $ 41,130 K
  • Annual Income, $ -110,420 K
  • 60-Month Beta 0.49
  • Price/Sales 3.94
  • Price/Cash Flow N/A
  • Price/Book 5.56
Trade IMTX with:

Options Overview Details

View History
  • Implied Volatility 66.87% ( -3.36%)
  • Historical Volatility 55.08%
  • IV Percentile 58%
  • IV Rank 21.47%
  • IV High 271.68% on 03/18/22
  • IV Low 10.86% on 06/06/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 1,897
  • Open Int (30-Day) 2,245

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.35
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.46
  • Prior Year -0.30
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.66 +8.88%
on 01/26/23
9.48 -12.03%
on 01/06/23
-0.23 (-2.68%)
since 01/03/23
3-Month
7.66 +8.88%
on 01/26/23
11.45 -27.16%
on 12/08/22
-2.32 (-21.76%)
since 11/03/22
52-Week
5.75 +45.04%
on 05/12/22
13.60 -38.68%
on 09/09/22
-0.94 (-10.13%)
since 02/03/22

Most Recent Stories

More News
Immatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates

Immatics (IMTX) delivered earnings and revenue surprises of -3.23% and 13.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

IMTX : 8.34 (-2.80%)
USAQ : 0.1700 (+20.57%)
Immatics: Q3 Earnings Snapshot

Immatics: Q3 Earnings Snapshot

IMTX : 8.34 (-2.80%)
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates

Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of -60% and 22.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

DNA : 2.06 (-5.94%)
IMTX : 8.34 (-2.80%)
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates

Tango Therapeutics, Inc. (TNGX) delivered earnings and revenue surprises of -3.13% and 15.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

TNGX : 6.54 (-6.97%)
IMTX : 8.34 (-2.80%)
Vericel Corporation (VCEL) Reports Q3 Loss, Lags Revenue Estimates

Vericel Corporation (VCEL) delivered earnings and revenue surprises of -16.67% and 3.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

VCEL : 31.06 (-0.89%)
IMTX : 8.34 (-2.80%)
Does Immatics (IMTX) Have the Potential to Rally 77% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 76.9% in Immatics (IMTX). While the effectiveness of this highly sought-after metric is questionable, the positive...

IMTX : 8.34 (-2.80%)
Wall Street Analysts See an 81% Upside in Immatics (IMTX): Can the Stock Really Move This High?

The mean of analysts' price targets for Immatics (IMTX) points to an 81.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

IMTX : 8.34 (-2.80%)
Immatics (IMTX) Moves 11.6% Higher: Will This Strength Last?

Immatics (IMTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

IMTX : 8.34 (-2.80%)
ANIK : 32.10 (+0.82%)
Wall Street Analysts Think Immatics (IMTX) Could Surge 82%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 81.5% in Immatics (IMTX). While the effectiveness of this highly sought-after metric is questionable, the positive...

IMTX : 8.34 (-2.80%)
Immatics (IMTX) Reports Q2 Loss, Lags Revenue Estimates

Immatics (IMTX) delivered earnings and revenue surprises of -276.92% and 56.96%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

IMTX : 8.34 (-2.80%)
VYNT : 0.8300 (-19.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Immatics N.V. engages in the discovery of targets for cancer immunotherapies. It is developing targeted immunotherapies with focus on treating solid tumors. Immatics N.V., formerly known as ARYA SCIENCES, is based in Tuebingen, Germany.

See More

Key Turning Points

3rd Resistance Point 8.83
2nd Resistance Point 8.73
1st Resistance Point 8.53
Last Price 8.34
1st Support Level 8.23
2nd Support Level 8.13
3rd Support Level 7.93

See More

52-Week High 13.60
Fibonacci 61.8% 10.60
Fibonacci 50% 9.68
Fibonacci 38.2% 8.75
Last Price 8.34
52-Week Low 5.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar